This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Tantawy AAG. Molecular genetics of hemophilia A: clinical perspectives. Egypt J Med Hum Genet 2010; 11: 105–14. doi:10.1016/j.ejmhg.2010.10.005.TantawyAAGMolecular genetics of hemophilia A: clinical perspectivesEgypt J Med Hum Genet2010111051410.1016/j.ejmhg.2010.10.005Open DOISearch in Google Scholar
Ibrahim UA, Ahmed SG. Pathophysiology of bleeding diathesis in haemophilia-A: a sequential and critical appraisal of non-FVIII related haemostatic dysfunctions and their therapeutic implications. Egypt J Med Hum Genet 2018; 19: 285–95. doi:10.1016/j.ejmhg.2018.01.003.IbrahimUAAhmedSGPathophysiology of bleeding diathesis in haemophilia-A: a sequential and critical appraisal of non-FVIII related haemostatic dysfunctions and their therapeutic implicationsEgypt J Med Hum Genet2018192859510.1016/j.ejmhg.2018.01.003Open DOISearch in Google Scholar
Brinkmann T, Kähnert H, Prohaska W, et al Synthesis of tissue factor pathway inhibitor in human synovial cells and chondrocytes makes joints the predilected site of bleeding in haemophiliacs. Eur J Clin Chem Clin Biochem 1994; 32 :313–7.BrinkmannTKähnertHProhaskaWet alSynthesis of tissue factor pathway inhibitor in human synovial cells and chondrocytes makes joints the predilected site of bleeding in haemophiliacsEur J Clin Chem Clin Biochem199432313710.1515/cclm.1994.32.4.3137518699Search in Google Scholar
Nieuwenhuizen L, Schutgens RE, van Asbeck BS, et al Identification and expression of iron regulators in human synovium: evidence for upregulation in haemophilic arthropathy compared to rheumatoid arthritis, osteoarthritis, and healthy controls. Haemophilia 2013; 19: e218–e227. doi:10.1111/hae.12208.NieuwenhuizenLSchutgensREvan AsbeckBSet alIdentification and expression of iron regulators in human synovium: evidence for upregulation in haemophilic arthropathy compared to rheumatoid arthritis, osteoarthritis, and healthy controlsHaemophilia201319e218e22710.1111/hae.1220823777533Open DOISearch in Google Scholar
Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134(5): 1087–97.DrakeTAMorrisseyJHEdgingtonTSSelective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosisAm J Pathol19891345108797Search in Google Scholar
Chu AJ. Tissue factor, blood coagulation, and beyond: an overview. Int J Inflam 2011; 367284. doi: 10.4061/2011/367284.ChuAJTissue factor, blood coagulation, and beyond: an overviewInt J Inflam201136728410.4061/2011/367284317649521941675Open DOISearch in Google Scholar
Qasim Z, Naseem L, Asif N, Hassan K. Haemophilia: pattern of clinical presentation and disease severity. Int J Pathol 2013; 11: 58–63.QasimZNaseemLAsifNHassanKHaemophilia: pattern of clinical presentation and disease severityInt J Pathol2013115863Search in Google Scholar
Rodriguez-Merchan EC. Musculoskeletal complications of hemophilia. HSS J 2010; 6: 37–42. doi: 10.1007/s11420-009-9140-9.Rodriguez-MerchanEC.Musculoskeletal complications of hemophiliaHSS J20106374210.1007/s11420-009-9140-9282148719921342Open DOISearch in Google Scholar
Roussel NA. Gaining insight into the complexity of pain in patients with haemophilia: state-of-the-art review on pain processing. Haemophilia 2018; 24: 3–8. doi: 10.1111/ hae.13509.RousselNAGaining insight into the complexity of pain in patients with haemophilia: state-of-the-art review on pain processingHaemophilia2018243810.1111/hae.1350929878656Open DOISearch in Google Scholar
Ghosh K, Ghosh K. Management of haemophilia in developing countries: challenges and options. Indian J Hematol Blood Transfus 2016;32: 347–55. doi: 10.1007/s12288-015-0562-x.GhoshKGhoshKManagement of haemophilia in developing countries: challenges and optionsIndian J Hematol Blood Transfus2016323475510.1007/s12288-015-0562-x493074927429529Open DOISearch in Google Scholar
Ahmed SG, Kagu MB, Ibrahim UA. Pattern of blood products transfusions and reactions among multi-transfused haemophiliacs in Nigeria: implications on haemophilia care in low resource tropical settings. Sudan Med J 2018; 54: 29–38. doi: 10.12816/0046389.AhmedSGKaguMBIbrahimUAPattern of blood products transfusions and reactions among multi-transfused haemophiliacs in Nigeria: implications on haemophilia care in low resource tropical settingsSudan Med J201854293810.12816/0046389Open DOISearch in Google Scholar
Auerswald G, Dolan G, Duffy A, et al Pain and pain management in haemophilia. Blood Coagul Fibrinolysis 2016; 27: 845–54. doi: 10.1097/MBC.0000000000000571.AuerswaldGDolanGDuffyAet alPain and pain management in haemophiliaBlood Coagul Fibrinolysis2016278455410.1097/MBC.0000000000000571508756627439216Open DOISearch in Google Scholar
Volkow ND, McLellan AT. Opioid abuse in chronic pain – misconceptions and mitigation strategies. N Engl J Med 2016; 374: 1253–63. doi: 10.1056/NEJMra1507771.VolkowNDMcLellanATOpioid abuse in chronic pain – misconceptions and mitigation strategiesN Engl J Med201637412536310.1056/NEJMra150777127028915Open DOISearch in Google Scholar
Witkop M, Lambing A, Divine G, et al A national study of pain in the bleeding disorders community: a description of haemophilia pain. Haemophilia 2012; 18(3): e115–9. doi: 10.1111/j.1365-2516.2011.02709.x.WitkopMLambingADivineGet alA national study of pain in the bleeding disorders community: a description of haemophilia painHaemophilia2012183e115910.1111/j.1365-2516.2011.02709.x22171646Open DOISearch in Google Scholar
Forsyth AL, Gregory M, Nugent D, et al Haemophilia Experiences, Results and Opportunities (HERO) study: survey methodology and population demographics. Haemophilia 2014 20(1): 44–51. doi: 10.1111/hae.12239.ForsythALGregoryMNugentDet alHaemophilia Experiences, Results and Opportunities (HERO) study: survey methodology and population demographicsHaemophilia2014201445110.1111/hae.1223923902228Open DOISearch in Google Scholar
Forsyth AL, Witkop M, Lambing A, et al Associations of quality of life, pain, and self-reported arthritis with age, employment, bleed rate, and utilization of hemophilia center and health care provider services: results in adults in the HERO study. Patient Prefer Adherence 2015; 9: 1549–60. doi: 10.2147/PPA.S87659.ForsythALWitkopMLambingAet alAssociations of quality of life, pain, and self-reported arthritis with age, employment, bleed rate, and utilization of hemophilia center and health care provider services: results in adults in the HERO studyPatient Prefer Adherence2015915496010.2147/PPA.S87659463141926604708Open DOISearch in Google Scholar
Humphries TJ, Kessler CM. Managing chronic pain in adults with haemophilia: current status and call to action. Haemophilia 2015; 21:41–51. doi:10.1111/hae.12526.HumphriesTJKesslerCMManaging chronic pain in adults with haemophilia: current status and call to actionHaemophilia201521415110.1111/hae.1252625274075Open DOISearch in Google Scholar
Varni JW, Gilberta A. Self-regulation of chronic arthritic pain and long-term analgesic dependence in a haemophiliac. Rheumatol Rehabil 1982; 21: 171–4. doi: 10.1093/ rheumatology/21.3.171.VarniJWGilbertaASelf-regulation of chronic arthritic pain and long-term analgesic dependence in a haemophiliacRheumatol Rehabil198221171410.1093/rheumatology/21.3.1717100773Open DOISearch in Google Scholar
Laffan M, Manning R. Investigation of haemostasis. In: Lewis SM, Bain BJ, Bates I, eds. Practical Haematology 10th edn. London: Churchill Livingstone; 2006: 379–440.LaffanMManningRInvestigation of haemostasisLewisSMBainBJBatesIPractical Haematology10th ednLondonChurchill Livingstone200637944010.1016/B0-44-306660-4/50020-9Search in Google Scholar
Rowley M, Milkins C. Laboratory aspects of blood transfusion. In: Lewis SM, Bain BJ, Bates I, eds. Practical Haematology 10th edn. London: Churchill Livingstone; 2006: 523–54.RowleyMMilkinsCLaboratory aspects of blood transfusionLewisSMBainBJBatesIPractical Haematology10th ednLondonChurchill Livingstone20065235410.1016/B0-44-306660-4/50024-6Search in Google Scholar
Wild B, Bain BJ. Investigation of abnormal haemoglobins and thalassaemia. In: Lewis SM, Bain BJ, Bates I, eds. Practical Haematology 10th edn. London: Churchill Livingstone; 2006: 271–310.WildBBainBJInvestigation of abnormal haemoglobins and thalassaemiaLewisSMBainBJBatesIPractical Haematology10th ednLondonChurchill Livingstone200627131010.1016/B0-44-306660-4/50016-7Search in Google Scholar
Alhaosawi MM. Guidelines of management of musculoskeletal complications of hemophilia. J Appl Hematol 2014; 5: 75–85. doi: 10.4103/1658-5127.141988.AlhaosawiMMGuidelines of management of musculoskeletal complications of hemophiliaJ Appl Hematol20145758510.4103/1658-5127.141988Open DOISearch in Google Scholar
Arnold WD, Hilgartner MW. Hemophilic arthropathy. Current concepts of pathogenesis and management. J Bone Joint Surg Am 1977; 59(3): 287–305.ArnoldWDHilgartnerMWHemophilic arthropathy. Current concepts of pathogenesis and managementJ Bone Joint Surg Am197759328730510.2106/00004623-197759030-00001Search in Google Scholar
Gorfinkel L, Voon P, Wood E, Klimas J. Diagnosing opioid addiction in people with chronic pain BMJ 2018; 362:k3949. doi: 10.1136/bmj.k3949.GorfinkelLVoonPWoodEKlimasJDiagnosing opioid addiction in people with chronic painBMJ2018362k394910.1136/bmj.k394930242012Open DOISearch in Google Scholar
Mistry CJ, Bawor M, Desai D, et al Genetics of opioid dependence: a review of the genetic contribution to opioid dependence. Curr Psychiatry Rev 2014; 10: 156–67.MistryCJBaworMDesaiDet alGenetics of opioid dependence: a review of the genetic contribution to opioid dependenceCurr Psychiatry Rev2014101566710.2174/1573400510666140320000928415583225242908Search in Google Scholar
Ibrahim UA, Ahmed SG. Determinants and modifiers of bleeding phenotypes in haemophilia-A: general and tropical perspectives. Egypt J Med Hum Genet 2018; 19: 171–8. doi: 10.1016/j.ejmhg.2017.10.004.IbrahimUAAhmedSGDeterminants and modifiers of bleeding phenotypes in haemophilia-A: general and tropical perspectivesEgypt J Med Hum Genet201819171810.1016/j.ejmhg.2017.10.004Open DOISearch in Google Scholar
Sharathkumar A, Lillicrap D, Blanchette VS, et al Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A. J Thromb Haemost 2003; 1: 1228–36.SharathkumarALillicrapDBlanchetteVSet alIntensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia AJ Thromb Haemost2003112283610.1046/j.1538-7836.2003.00230.x12871324Search in Google Scholar
Mathews V, Nair SC, David S, et al Management of hemophilia in patients with inhibitors: the perspective from developing countries. Semin Thromb Hemost 2009; 35: 820–6. doi: 10.1055/s-00 291245115.MathewsVNairSCDavidSet alManagement of hemophilia in patients with inhibitors: the perspective from developing countriesSemin Thromb Hemost200935820610.1055/s-00291245115Open DOISearch in Google Scholar
Stonebraker JS, Bolton-Maggs PH, et al A study of variations in the reported haemophilia A prevalence around the world. Haemophilia 2010; 16: 20–32. doi: 10.1111/j.1365-2516.2009.02127.x.StonebrakerJSBolton-MaggsPHet alA study of variations in the reported haemophilia A prevalence around the worldHaemophilia201016203210.1111/j.1365-2516.2009.02127.x19845775Open DOISearch in Google Scholar
Joint Formulary Committee. Drugs acting on the nervous system. British National Formulary 70. London: BMJ Group and Pharmaceutical Press; 2015: 262–437.Joint Formulary Committee. Drugs acting on the nervous systemBritish National Formulary70LondonBMJ Group and Pharmaceutical Press2015262437Search in Google Scholar
Kircher S, Zacny J, Apfelbaum SM, et al Understanding and treating opioid addiction in a patient with cancer pain. J Pain 2011; 12: 1025–31. doi: 10.1016/j.jpain.2011.07.006.KircherSZacnyJApfelbaumSMet alUnderstanding and treating opioid addiction in a patient with cancer painJ Pain20111210253110.1016/j.jpain.2011.07.00621968264Open DOISearch in Google Scholar
Zamora-Legoff JA, Achenbach SJ, Crowson CS, et al Opioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative study. Clin Rheumatol 2016; 35: 1137–44. doi: 10.1007/s10067-016-3239-4.Zamora-LegoffJAAchenbachSJCrowsonCSet alOpioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative studyClin Rheumatol20163511374410.1007/s10067-016-3239-4485055327022929Open DOISearch in Google Scholar
Ahmed SG, Ibrahim UA. The prevalence of therapeutic opiate dependence among patients with sickle cell disease in Maiduguri, north-east Nigeria. Nig J Pharm 2001; 32: 56–9.AhmedSGIbrahimUAThe prevalence of therapeutic opiate dependence among patients with sickle cell disease in Maiduguri, north-east NigeriaNig J Pharm200132569Search in Google Scholar
Ahmed SG, Ibrahim UA. Disease severity indices in sickle cell anaemia patients with therapeutic opiate dependence in Nigeria. Hamdard Med 2008; 51: 79–83.AhmedSGIbrahimUADisease severity indices in sickle cell anaemia patients with therapeutic opiate dependence in NigeriaHamdard Med2008517983Search in Google Scholar
Nossent AY, van Marion V, van Tilburg NH, et al von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis. J Thromb Haemost 2006; 4: 2556–62.NossentAYvan MarionVvan TilburgNHet alvon Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosisJ Thromb Haemost2006425566210.1111/j.1538-7836.2006.02273.x17059421Search in Google Scholar
Gallinaro L, Cattini MG, Sztukowska M, et al A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood 2008; 111: 3540–5. doi: 10.1182/ blood-2007-11-122945.GallinaroLCattiniMGSztukowskaMet alA shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factorBlood20081113540510.1182/blood-2007-11-12294518245665Open DOISearch in Google Scholar
Jenkins PV, O'Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 2006; 46: 1836–44.JenkinsPVO'DonnellJSABO blood group determines plasma von Willebrand factor levels: a biologic function after all?Transfusion20064618364410.1111/j.1537-2995.2006.00975.x17002642Search in Google Scholar
Federici AB. The factor VIII/von Willebrand factor complex: basic and clinical issues. Haematologica 2003; 88: EREP02.FedericiABThe factor VIII/von Willebrand factor complex: basic and clinical issuesHaematologica200388EREP02Search in Google Scholar
Song J, Chen F, Campos M, et al Quantitative influence of ABO blood groups on factor VIII and its ratio to von Willebrand factor, novel observations from an ARIC study of 11,673 subjects. PLoS One 2015; 10: e0132626. doi: 10.1371/journal. pone.0132626.SongJChenFCamposMet alQuantitative influence of ABO blood groups on factor VIII and its ratio to von Willebrand factor, novel observations from an ARIC study of 11,673 subjectsPLoS One201510e013262610.1371/journal.pone.0132626452656726244499Open DOISearch in Google Scholar
Reininger AJ, Heijnen HF, Schumann H, et al Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 2006; 107: 3537–45. doi: 10.1182/blood-2005-02-0618.ReiningerAJHeijnenHFSchumannHet alMechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stressBlood200610735374510.1182/blood-2005-02-0618189577016449527Open DOISearch in Google Scholar
Dentali F, Sironi AP, Ageno W, et al Non-O blood type is the commonest genetic risk factor for VTE: results from a metaanalysis of the literature. Semin Thromb Hemost 2012; 38: 535–48. doi: 10.1055/s-0032-1315758.DentaliFSironiAPAgenoWet alNon-O blood type is the commonest genetic risk factor for VTE: results from a metaanalysis of the literatureSemin Thromb Hemost2012385354810.1055/s-0032-131575822740183Open DOISearch in Google Scholar
Reddy VM, Daniel M, Bright E, et al Is there an association between blood group O and epistaxis? J Laryngol Otol 2008; 122: 366–8.ReddyVMDanielMBrightEet alIs there an association between blood group O and epistaxis?J Laryngol Otol2008122366810.1017/S002221510700856017537274Search in Google Scholar
Welsby IJ, Jones R, Pylman J, et al ABO blood group and bleeding after coronary artery bypass graft surgery. Blood Coagul Fibrinolysis 2007; 18: 781–5.WelsbyIJJonesRPylmanJet alABO blood group and bleeding after coronary artery bypass graft surgeryBlood Coagul Fibrinolysis200718781510.1097/MBC.0b013e3282f1029c17982320Search in Google Scholar
Franchini M, Crestani S, Frattini F, et al Relationship between ABO blood group and bleeding complications in orally anticoagulated patients. J Thromb Haemost 2012; 10: 1688– 91. doi: 10.1111/j.1538-7836.2012.04785.x.FranchiniMCrestaniSFrattiniFet alRelationship between ABO blood group and bleeding complications in orally anticoagulated patientsJ Thromb Haemost20121016889110.1111/j.1538-7836.2012.04785.x22606934Open DOISearch in Google Scholar
Ahmed SG, Kagu MB, Ibrahim UA. Correlation between ABO blood groups and spontaneous bleeding rates in severe haemophilia-A. Sudan Med J 2017; 53: 162–9. Available from http://www.smj.eg.net/journals/pdf/825.pdf (accessed 4 April 2019).AhmedSGKaguMBIbrahimUACorrelation between ABO blood groups and spontaneous bleeding rates in severe haemophilia-ASudan Med J2017531629Available fromhttp://www.smj.eg.net/journals/pdf/825.pdfaccessed 4 April 201910.12816/0043054Search in Google Scholar
Hazendonk HC, Lock J, Mathôt RA, et al Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications. J Thromb Haemost 2016; 14: 468–78. doi:10.1111/ jth.13242.HazendonkHCLockJMathôtRAet alPerioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complicationsJ Thromb Haemost2016144687810.1111/jth.1324226714028Open DOISearch in Google Scholar
Fleming AF, Storey J, Molineaux L, et al Abnormal haemoglobins in the Sudan savanna of Nigeria: I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol 1979; 73: 161–72.FlemingAFStoreyJMolineauxLet alAbnormal haemoglobins in the Sudan savanna of Nigeria: I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survivalAnn Trop Med Parasitol1979731617210.1080/00034983.1979.11687243315211Search in Google Scholar
Elguero E, Délicat-Loembet LM, Rougeron V, et al Malaria continues to select for sickle cell trait in Central Africa. Proc Natl Acad Sci USA 2015; 112: 7051–4. doi: 10.1073/pnas.1505665112.ElgueroEDélicat-LoembetLMRougeronVet alMalaria continues to select for sickle cell trait in Central AfricaProc Natl Acad Sci USA20151127051410.1073/pnas.1505665112446050625941403Open DOISearch in Google Scholar
PO Olatunji. Malaria and the sickle gene: polymorphism balance in favour of eradication Ann Health Res 2018; 4: 88–96. doi: 10.30442/ahr.0402-1-12.PO OlatunjiMalaria and the sickle gene: polymorphism balance in favour of eradicationAnn Health Res20184889610.30442/ahr.0402-1-12Open DOISearch in Google Scholar
Gong L, Parikh S, Rosenthal PJ, Greenhouse B. Biochemical and immunological mechanisms by which sickle cell trait protects against malaria. Malar J 2013; 12: 317. doi: 10.1186/1475-2875-12-317.GongLParikhSRosenthalPJGreenhouseBBiochemical and immunological mechanisms by which sickle cell trait protects against malariaMalar J20131231710.1186/1475-2875-12-317384728524025776Open DOISearch in Google Scholar
Westerman MP, Green D, Gilman-Sachs A, et al Coagulation changes in individuals with sickle cell trait. Am J Hematol 2002; 69: 89–94. doi: 10.1002/ajh.10021.WestermanMPGreenDGilman-SachsAet alCoagulation changes in individuals with sickle cell traitAm J Hematol200269899410.1002/ajh.1002111835343Open DOISearch in Google Scholar
Tait JF, Gibson D. Measurement of membrane phospholipid asymmetry in normal and sickle cell erythrocytes by means of annexin V binding. J Lab Clin Med 1994; 123: 741–8.TaitJFGibsonDMeasurement of membrane phospholipid asymmetry in normal and sickle cell erythrocytes by means of annexin V bindingJ Lab Clin Med19941237418Search in Google Scholar
Westerman MP, Cole ER, Wu K. The effect of spicules obtained from sickle red cells on clotting activity. Br J Haematol 1984; 56: 557–62.WestermanMPColeERWuKThe effect of spicules obtained from sickle red cells on clotting activityBr J Haematol1984565576210.1111/j.1365-2141.1984.tb02180.x6424699Search in Google Scholar
Austin H, Key NS, Benson JM, et al Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 2007; 110: 908–12. doi: 10.1182/blood-2006-11-057604.AustinHKeyNSBensonJMet alSickle cell trait and the risk of venous thromboembolism among blacksBlood20071109081210.1182/blood-2006-11-05760417409269Open DOISearch in Google Scholar
Ahmed SG, Ibrahim UA, Kagu MB, Abjah UA. Does sickle cell trait reduce the frequency of spontaneous bleeds in severe haemophilia? J Haem Pract 2016; 3: 1–5. doi: 10.17225/ jhp-00083.AhmedSGIbrahimUAKaguMBAbjahUA Does sickle cell trait reduce the frequency of spontaneous bleeds in severe haemophilia?J Haem Pract201631510.17225/jhp-00083Open DOISearch in Google Scholar
Dhiman P, Chaudhary R, Sudha K. Sickle cell-ß thalassemia with concomitant hemophilia A: a rare presentation. Blood Res 2015; 50: 264–67. doi: 10.5045/br.2015.50.4.264.DhimanPChaudharyRSudhaKSickle cell-ß thalassemia with concomitant hemophilia A: a rare presentationBlood Res2015502646710.5045/br.2015.50.4.264470505626770958Open DOISearch in Google Scholar
Qasim Z. Pattern of haemarthrosis in haemophilia. J Rawalpindi Med College 2013; 17: 204–6. Available from https://www.journalrmc.com/volumes/1395217838.pdf (accessed 4 April 2019).QasimZPattern of haemarthrosis in haemophiliaJ Rawalpindi Med College2013172046Available fromhttps://www.journalrmc.com/volumes/1395217838.pdfaccessed 4 April 2019Search in Google Scholar
Melchiorre D, Manetti M, Matucci-Cerinic M. Pathophysiology of hemophilic arthropathy. J Clin Med 2017; 6: 63. doi: 10.3390/jcm6070063.MelchiorreDManettiMMatucci-CerinicMPathophysiology of hemophilic arthropathyJ Clin Med201766310.3390/jcm6070063553257128672826Open DOISearch in Google Scholar
Chang CY, Li TY, Cheng SN, et al Prevalence and severity by age and other clinical correlates of haemophilic arthropathy of the elbow, knee and ankle among Taiwanese patients with haemophilia. Haemophilia 2017; 23: 284–91. doi: 10.1111/ hae.13117.ChangCYLiTYChengSNet alPrevalence and severity by age and other clinical correlates of haemophilic arthropathy of the elbow, knee and ankle among Taiwanese patients with haemophiliaHaemophilia2017232849110.1111/hae.1311727862662Open DOISearch in Google Scholar
Rodriguez-Merchan EC. Prevention of the musculoskeletal complications of hemophilia. Adv Prev Med 2012: 201271. doi: 10.1155/2012/201271.Rodriguez-MerchanEC.Prevention of the musculoskeletal complications of hemophiliaAdv Prev Med201220127110.1155/2012/201271338492722778972Open DOISearch in Google Scholar
, 